142 related articles for article (PubMed ID: 16828588)
1. Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation.
Tiukinhoy-Laing SD; Rossi JS; Bayram M; De Luca L; Gafoor S; Blei A; Flamm S; Davidson CJ; Gheorghiade M
Am J Cardiol; 2006 Jul; 98(2):178-81. PubMed ID: 16828588
[TBL] [Abstract][Full Text] [Related]
2. The role of coronary calcium score in the risk assessment of liver transplant candidates.
Kemmer N; Case J; Chandna S; Neff GW
Transplant Proc; 2014; 46(1):230-3. PubMed ID: 24507057
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of coronary artery disease in liver transplant candidates over age 50.
Carey WD; Dumot JA; Pimentel RR; Barnes DS; Hobbs RE; Henderson JM; Vogt DP; Mayes JT; Westveer MK; Easley KA
Transplantation; 1995 Mar; 59(6):859-64. PubMed ID: 7701580
[TBL] [Abstract][Full Text] [Related]
4. Multivessel coronary artery disease predicts mortality, length of stay, and pressor requirements after liver transplantation.
Yong CM; Sharma M; Ochoa V; Abnousi F; Roberts J; Bass NM; Niemann CU; Shiboski S; Prasad M; Tavakol M; Ports TA; Gregoratos G; Yeghiazarians Y; Boyle AJ
Liver Transpl; 2010 Nov; 16(11):1242-8. PubMed ID: 21031539
[TBL] [Abstract][Full Text] [Related]
5. Safety of transradial cardiac catheterization in patients with end-stage liver disease.
Jacobs E; Singh V; Damluji A; Shah NR; Warsch JL; Ghanta R; Martin P; Alfonso CE; Martinez CA; Moscucci M; Cohen MG
Catheter Cardiovasc Interv; 2014 Feb; 83(3):360-6. PubMed ID: 23723127
[TBL] [Abstract][Full Text] [Related]
6. Clinical Utility of a Risk-Adapted Protocol for the Evaluation of Coronary Artery Disease in Liver Transplant Recipients.
Romero-Cristóbal M; Mombiela T; Caballero A; Clemente A; Fernández-Yunquera A; Diaz-Fontenla F; Rincón D; Ripoll C; Bermejo J; Catalina MV; Matilla AM; Ibáñez-Samaniego L; Pérez-Peña J; López-Baena JÁ; Díaz-Zorita B; Fernández-Avilés F; Salcedo MM; Bañares R
Liver Transpl; 2019 Aug; 25(8):1177-1186. PubMed ID: 31106506
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of cardiac risk factors in women 45 years of age or younger undergoing angiography for evaluation of undiagnosed chest pain.
De S; Searles G; Haddad H
Can J Cardiol; 2002 Sep; 18(9):945-8. PubMed ID: 12368928
[TBL] [Abstract][Full Text] [Related]
8. Myocardial perfusion imaging is an effective screening test for coronary artery disease in liver transplant candidates.
Baker S; Chambers C; McQuillan P; Janicki P; Kadry Z; Bowen D; Bezinover D
Clin Transplant; 2015 Apr; 29(4):319-26. PubMed ID: 25604507
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease.
Patel S; Kiefer TL; Ahmed A; Ali ZA; Tremmel JA; Lee DP; Yeung AC; Fearon WF
Am J Cardiol; 2011 Dec; 108(11):1552-5. PubMed ID: 21890080
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndrome.
Blei AT; Mazhar S; Davidson CJ; Flamm SL; Abecassis M; Gheorghiade M
J Clin Gastroenterol; 2007; 41 Suppl 3():S323-9. PubMed ID: 17975484
[TBL] [Abstract][Full Text] [Related]
11. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.
Gavazzi A; Berzuini C; Campana C; Inserra C; Ponzetta M; Sebastiani R; Ghio S; Recusani F
J Heart Lung Transplant; 1997 Jul; 16(7):774-85. PubMed ID: 9257260
[TBL] [Abstract][Full Text] [Related]
12. Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease.
Sorajja P; Ommen SR; Nishimura RA; Gersh BJ; Berger PB; Tajik AJ
Circulation; 2003 Nov; 108(19):2342-8. PubMed ID: 14581405
[TBL] [Abstract][Full Text] [Related]
13. Transient ischemic left ventricular cavity dilation is a significant predictor of severe and extensive coronary artery disease and adverse outcome in patients undergoing stress echocardiography.
Yao SS; Shah A; Bangalore S; Chaudhry FA
J Am Soc Echocardiogr; 2007 Apr; 20(4):352-8. PubMed ID: 17400113
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of, and risk factors for, angiographically determined coronary artery disease in type I-diabetic patients with nephropathy.
Manske CL; Wilson RF; Wang Y; Thomas W
Arch Intern Med; 1992 Dec; 152(12):2450-5. PubMed ID: 1456856
[TBL] [Abstract][Full Text] [Related]
15. Relation of microalbuminuria and coronary artery disease in patients with and without diabetes mellitus.
Sukhija R; Aronow WS; Kakar P; Garza L; Sachdeva R; Sinha A; Mehta JL
Am J Cardiol; 2006 Aug; 98(3):279-81. PubMed ID: 16860009
[TBL] [Abstract][Full Text] [Related]
16. Risk scores do not predict high mortality after coronary artery bypass surgery in the presence of diastolic dysfunction.
Merello L; Riesle E; Alburquerque J; Torres H; Aránguiz-Santander E; Pedemonte O; Westerberg B
Ann Thorac Surg; 2008 Apr; 85(4):1247-55. PubMed ID: 18355505
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: a computed tomography angiography study 2：.
Idilman IS; Akata D; Hazirolan T; Doganay Erdogan B; Aytemir K; Karcaaltincaba M
J Diabetes; 2015 Mar; 7(2):279-86. PubMed ID: 24893617
[TBL] [Abstract][Full Text] [Related]
18. CAD-LT score effectively predicts risk of significant coronary artery disease in liver transplant candidates.
Rachwan RJ; Kutkut I; Timsina LR; Bou Chaaya RG; El-Am EA; Sabra M; Mshelbwala FS; Rahal MA; Lacerda MA; Kubal CA; Fridell JA; Ghabril MS; Bourdillon PD; Mangus RS
J Hepatol; 2021 Jul; 75(1):142-149. PubMed ID: 33476745
[TBL] [Abstract][Full Text] [Related]
19. The diagnostic and prognostic utility of risk factors defined by the AHA/ACCF on the evaluation of cardiac disease in liver transplantation candidates.
Alexander S; Teshome M; Patel H; Chan EY; Doukky R
BMC Cardiovasc Disord; 2019 May; 19(1):102. PubMed ID: 31046672
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation.
Mehra MR; Uber PA; Potluri S; Ventura HO; Scott RL; Park MH
Am J Cardiol; 2004 Aug; 94(4):454-8. PubMed ID: 15325928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
